Millipede AspiRation for Revascularization in Stroke (MARRS) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.
Also called NCT05714501
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 235 participants
- Sponsor
- Perfuze
- Registry
-
NCT05714501
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, France, Spain
- Registry status
- Completed
Technical summary
Registry record NCT05714501. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-09 (actual); primary completion 2025-03-08 (actual). Results posted on 2026-07-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Millipede AspiRation for Revascularization in Stroke (MARRS) Study
- Acronym
- MARRS
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- Millipede System
- Lead sponsor
- Perfuze
Record details
- Record id
cardio:ct-nct05714501- Content hash
92650cf94525811979101395b049659ea077f954ac42f12a28063bd764178c5f